Tactile Systems Technology stock price drops below 50-day average

Analysts weigh in on whether it's time to sell the medical device company's shares

Mar. 6, 2026 at 10:49am

Got story updates? Submit your updates here. ›

Shares of Tactile Systems Technology (NASDAQ:TCMD) fell below their 50-day moving average on Thursday, raising questions about the stock's performance. The company, which makes home-use pneumatic compression therapy systems, has seen its stock price fluctuate in recent months as Wall Street analysts offer mixed views on the company's outlook.

Why it matters

Tactile Systems Technology is a key player in the medical device industry, providing treatments for lymphedema and other chronic edema-related conditions. The company's stock performance is closely watched by investors as an indicator of its financial health and market position.

The details

Tactile Systems Technology's stock price closed at $29.41 on Thursday, with the stock trading as low as $29.06 during the session. The company's 50-day moving average is $29.10, suggesting the stock has dipped below this key technical indicator. Wall Street analysts have a range of views on the stock, with some maintaining a 'Moderate Buy' rating and others suggesting it may be time to sell.

  • Tactile Systems Technology's stock price crossed below its 50-day moving average on Thursday, March 6, 2026.

The players

Tactile Systems Technology, Inc.

A medical device company that specializes in the design, manufacture, and marketing of home-use pneumatic compression therapy systems for the treatment of lymphedema and other chronic edema-related conditions.

Raymond James Financial

A financial services firm that has set a $35.00 price target for Tactile Systems Technology's stock.

Zacks Research

A research firm that has lowered its rating on Tactile Systems Technology's stock from 'strong-buy' to 'hold'.

B. Riley Financial

A financial services firm that has boosted its price target for Tactile Systems Technology's stock from $16.00 to $32.00 and maintained a 'neutral' rating.

BTIG Research

A research firm that has increased its price target for Tactile Systems Technology's stock from $36.00 to $38.00 and maintained a 'buy' rating.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee

The takeaway

Tactile Systems Technology's stock performance is a closely watched indicator in the medical device industry, and the company's recent dip below its 50-day moving average has raised questions about its future outlook. Investors and analysts will be closely monitoring the company's financial results and market position in the coming months to determine whether the stock is a buy or a sell.